S
Shanghai Yirijian Digital Intelligence Health Pharmaceutical
A provider of digital and intelligent solutions for the pharmaceutical industry
At a glance
- Status
- Operational
- Open positions
- None listed
- Dealroom signal
- 15.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- B2B
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Apr 2023 | $2.8M | $578M | Hillhouse Capital · Chuangxin Gongchang | ↗ |
| EARLY VC✓Equity / VC | Dec 2022 | $41M | $454M | IDG Capital · JD Digits · CR Capital Management | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Shanghai Yirijian Digital Intelligence Health Pharmaceutical in its local ecosystem
The Shanghai Yirijian Digital Intelligence Health Pharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
IDG Capital
JD Digits- CMCR Capital Management
Hillhouse Capital
Chuangxin Gongchang
Source: Dealroom Talent Intelligence.
Global footprint
See Shanghai Yirijian Digital Intelligence Health Pharmaceutical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









